These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39004634)

  • 1. Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.
    Sibert BS; Kim JY; Yang JE; Ke Z; Stobart CC; Moore ML; Wright ER
    Nat Commun; 2024 Jul; 15(1):5923. PubMed ID: 39004634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helical ordering of envelope-associated proteins and glycoproteins in respiratory syncytial virus.
    Conley MJ; Short JM; Burns AM; Streetley J; Hutchings J; Bakker SE; Power BJ; Jaffery H; Haney J; Zanetti G; Murcia PR; Stewart M; Fearns R; Vijayakrishnan S; Bhella D
    EMBO J; 2022 Feb; 41(3):e109728. PubMed ID: 34935163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.
    Shaikh FY; Cox RG; Lifland AW; Hotard AL; Williams JV; Moore ML; Santangelo PJ; Crowe JE
    mBio; 2012; 3(1):. PubMed ID: 22318318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.
    Ke Z; Dillard RS; Chirkova T; Leon F; Stobart CC; Hampton CM; Strauss JD; Rajan D; Rostad CA; Taylor JV; Yi H; Shah R; Jin M; Hartert TV; Peebles RS; Graham BS; Moore ML; Anderson LJ; Wright ER
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30127286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.
    Kiss G; Holl JM; Williams GM; Alonas E; Vanover D; Lifland AW; Gudheti M; Guerrero-Ferreira RC; Nair V; Yi H; Graham BS; Santangelo PJ; Wright ER
    J Virol; 2014 Jul; 88(13):7602-17. PubMed ID: 24760890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design.
    DeFord DM; Nosek JM; Castiglia KR; Hasik EF; Franke ME; Nick BC; Abdelnour AM; Haas CE; Junod NA; Latsko KN; Moore ML; Berthrong ST; Rostad CA; Stobart CC
    J Gen Virol; 2019 Jul; 100(7):1112-1122. PubMed ID: 31184573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution.
    Krueger S; Curtis JE; Scott DR; Grishaev A; Glenn G; Smith G; Ellingsworth L; Borisov O; Maynard EL
    Mol Pharm; 2021 Jan; 18(1):359-376. PubMed ID: 33322901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient opening of trimeric prefusion RSV F proteins.
    Gilman MSA; Furmanova-Hollenstein P; Pascual G; B van 't Wout A; Langedijk JPM; McLellan JS
    Nat Commun; 2019 May; 10(1):2105. PubMed ID: 31068578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Architecture of respiratory syncytial virus revealed by electron cryotomography.
    Liljeroos L; Krzyzaniak MA; Helenius A; Butcher SJ
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11133-8. PubMed ID: 23776214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of respiratory syncytial virus surface glycoproteins.
    McLellan JS; Ray WC; Peeples ME
    Curr Top Microbiol Immunol; 2013; 372():83-104. PubMed ID: 24362685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    Xun G; Song X; Hu J; Zhang H; Liu L; Zhang Z; Gong R
    J Virol; 2021 Aug; 95(18):e0048521. PubMed ID: 34160257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
    Boyington JC; Joyce MG; Sastry M; Stewart-Jones GB; Chen M; Kong WP; Ngwuta JO; Thomas PV; Tsybovsky Y; Yang Y; Zhang B; Chen L; Druz A; Georgiev IS; Ko K; Zhou T; Mascola JR; Graham BS; Kwong PD
    PLoS One; 2016; 11(7):e0159709. PubMed ID: 27463224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
    Liang B; Ngwuta JO; Surman S; Kabatova B; Liu X; Lingemann M; Liu X; Yang L; Herbert R; Swerczek J; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
    Harshbarger W; Abeyrathne PD; Tian S; Huang Y; Chandramouli S; Bottomley MJ; Malito E
    MAbs; 2021; 13(1):1955812. PubMed ID: 34420474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation.
    Meshram CD; Baviskar PS; Ognibene CM; Oomens AGP
    J Virol; 2016 Dec; 90(23):10612-10628. PubMed ID: 27654298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
    Swanson KA; Settembre EC; Shaw CA; Dey AK; Rappuoli R; Mandl CW; Dormitzer PR; Carfi A
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9619-24. PubMed ID: 21586636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells.
    Trevisan M; Di Antonio V; Radeghieri A; Palù G; Ghildyal R; Alvisi G
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29510513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficiency of p27 Cleavage during
    Rezende W; Ye X; Angelo LS; Carisey AF; Avadhanula V; Piedra PA
    J Virol; 2023 May; 97(5):e0025423. PubMed ID: 37133390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.